Extended spectrum beta lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII Region
The resistance of Acinetobacter baumannii to ss-lactam antibiotics is mainly due to the synthesis of ss-lactamases. From a clinical point of view, this bacteria and others, grouped under the acronym SPACE (S: Serratia, P: Pseudomonas, A: Acinetobacter, C: Citrobacter, E: Enterobacter) are essentiall...
Gespeichert in:
Veröffentlicht in: | Revista chilena de infectología 2007-04, Vol.24 (2), p.137 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | 137 |
container_title | Revista chilena de infectología |
container_volume | 24 |
creator | Pino I, Carolina Domínguez Y, Mariana González R, Gerardo Bello T, Helia Sepúlveda A, Marcela Mella M, Sergio Zemelman M, Claudia Zemelman Z, Raúl |
description | The resistance of Acinetobacter baumannii to ss-lactam antibiotics is mainly due to the synthesis of ss-lactamases. From a clinical point of view, this bacteria and others, grouped under the acronym SPACE (S: Serratia, P: Pseudomonas, A: Acinetobacter, C: Citrobacter, E: Enterobacter) are essentially Amp-C ss-lactamases producers. There is no local information about ESBL presence in Acinetobacter. We studied ESBL production using the Ho and col. technique modified by adding cloxacillin as chromosomal ss-lactamases inhibitor. From 69 isolates, with resistance to at least one third generation cephalosporin, only 7 showed positive synergy test. Four of these amplified for TEM family gene, and one of these amplified also for the OXA family. Our study found a low ESBL production percentage, which agrees with the premise of Amp-C as the main mechanism of resistance to ss-lactam antibiotics in A. baumannii. However, the ESBL description in these bacteria emphasizes the capacity of expressing multiple resistance mechanisms. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17453072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17453072</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-4dbe46d95c8291156e52572dabdf2d059bf360cb5a0483012578c1177721af9a3</originalsourceid><addsrcrecordid>eNo1kM1KxDAUhbNQnHH0FeQudVFI0qZpl-MwOoUBwb_tcNOkM5E2KUkK-hS-sgV1dRbf4TtwzsiSSlZmjLJqQS5j_KCUy5KxC7JgshA5lXxJvrefyThtNMTRtClMAyiTEHpsEw4YTYTb7cv9_g7G4PXUJusdWAfr1jqTvJprJoDCaUDnrIWYAloXwUbfY5q1XfADbE62N-jg5ONoE_ZxHum9O1p3hOThvWkaeDbH2X1FzruZm-u_XJG3h-3rZpftnx6bzXqfjYxWKSu0MkWpa9FWvGZMlEZwIblGpTuuqahVl5e0VQJpUeWUzbBqGZNScoZdjfmK3Px6x0kNRh_GYAcMX4f_Z_Ifz5dgiw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Extended spectrum beta lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII Region</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Pino I, Carolina ; Domínguez Y, Mariana ; González R, Gerardo ; Bello T, Helia ; Sepúlveda A, Marcela ; Mella M, Sergio ; Zemelman M, Claudia ; Zemelman Z, Raúl</creator><creatorcontrib>Pino I, Carolina ; Domínguez Y, Mariana ; González R, Gerardo ; Bello T, Helia ; Sepúlveda A, Marcela ; Mella M, Sergio ; Zemelman M, Claudia ; Zemelman Z, Raúl</creatorcontrib><description>The resistance of Acinetobacter baumannii to ss-lactam antibiotics is mainly due to the synthesis of ss-lactamases. From a clinical point of view, this bacteria and others, grouped under the acronym SPACE (S: Serratia, P: Pseudomonas, A: Acinetobacter, C: Citrobacter, E: Enterobacter) are essentially Amp-C ss-lactamases producers. There is no local information about ESBL presence in Acinetobacter. We studied ESBL production using the Ho and col. technique modified by adding cloxacillin as chromosomal ss-lactamases inhibitor. From 69 isolates, with resistance to at least one third generation cephalosporin, only 7 showed positive synergy test. Four of these amplified for TEM family gene, and one of these amplified also for the OXA family. Our study found a low ESBL production percentage, which agrees with the premise of Amp-C as the main mechanism of resistance to ss-lactam antibiotics in A. baumannii. However, the ESBL description in these bacteria emphasizes the capacity of expressing multiple resistance mechanisms.</description><identifier>ISSN: 0716-1018</identifier><identifier>PMID: 17453072</identifier><language>spa</language><publisher>Chile</publisher><subject>Acinetobacter baumannii - drug effects ; Acinetobacter baumannii - enzymology ; Acinetobacter baumannii - isolation & purification ; Anti-Bacterial Agents - pharmacology ; Bacterial Proteins - biosynthesis ; beta-Lactam Resistance ; beta-Lactamases - biosynthesis ; Chile ; Drug Resistance, Bacterial ; Humans ; Isoelectric Focusing ; Microbial Sensitivity Tests</subject><ispartof>Revista chilena de infectología, 2007-04, Vol.24 (2), p.137</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17453072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pino I, Carolina</creatorcontrib><creatorcontrib>Domínguez Y, Mariana</creatorcontrib><creatorcontrib>González R, Gerardo</creatorcontrib><creatorcontrib>Bello T, Helia</creatorcontrib><creatorcontrib>Sepúlveda A, Marcela</creatorcontrib><creatorcontrib>Mella M, Sergio</creatorcontrib><creatorcontrib>Zemelman M, Claudia</creatorcontrib><creatorcontrib>Zemelman Z, Raúl</creatorcontrib><title>Extended spectrum beta lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII Region</title><title>Revista chilena de infectología</title><addtitle>Rev Chilena Infectol</addtitle><description>The resistance of Acinetobacter baumannii to ss-lactam antibiotics is mainly due to the synthesis of ss-lactamases. From a clinical point of view, this bacteria and others, grouped under the acronym SPACE (S: Serratia, P: Pseudomonas, A: Acinetobacter, C: Citrobacter, E: Enterobacter) are essentially Amp-C ss-lactamases producers. There is no local information about ESBL presence in Acinetobacter. We studied ESBL production using the Ho and col. technique modified by adding cloxacillin as chromosomal ss-lactamases inhibitor. From 69 isolates, with resistance to at least one third generation cephalosporin, only 7 showed positive synergy test. Four of these amplified for TEM family gene, and one of these amplified also for the OXA family. Our study found a low ESBL production percentage, which agrees with the premise of Amp-C as the main mechanism of resistance to ss-lactam antibiotics in A. baumannii. However, the ESBL description in these bacteria emphasizes the capacity of expressing multiple resistance mechanisms.</description><subject>Acinetobacter baumannii - drug effects</subject><subject>Acinetobacter baumannii - enzymology</subject><subject>Acinetobacter baumannii - isolation & purification</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacterial Proteins - biosynthesis</subject><subject>beta-Lactam Resistance</subject><subject>beta-Lactamases - biosynthesis</subject><subject>Chile</subject><subject>Drug Resistance, Bacterial</subject><subject>Humans</subject><subject>Isoelectric Focusing</subject><subject>Microbial Sensitivity Tests</subject><issn>0716-1018</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kM1KxDAUhbNQnHH0FeQudVFI0qZpl-MwOoUBwb_tcNOkM5E2KUkK-hS-sgV1dRbf4TtwzsiSSlZmjLJqQS5j_KCUy5KxC7JgshA5lXxJvrefyThtNMTRtClMAyiTEHpsEw4YTYTb7cv9_g7G4PXUJusdWAfr1jqTvJprJoDCaUDnrIWYAloXwUbfY5q1XfADbE62N-jg5ONoE_ZxHum9O1p3hOThvWkaeDbH2X1FzruZm-u_XJG3h-3rZpftnx6bzXqfjYxWKSu0MkWpa9FWvGZMlEZwIblGpTuuqahVl5e0VQJpUeWUzbBqGZNScoZdjfmK3Px6x0kNRh_GYAcMX4f_Z_Ifz5dgiw</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Pino I, Carolina</creator><creator>Domínguez Y, Mariana</creator><creator>González R, Gerardo</creator><creator>Bello T, Helia</creator><creator>Sepúlveda A, Marcela</creator><creator>Mella M, Sergio</creator><creator>Zemelman M, Claudia</creator><creator>Zemelman Z, Raúl</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200704</creationdate><title>Extended spectrum beta lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII Region</title><author>Pino I, Carolina ; Domínguez Y, Mariana ; González R, Gerardo ; Bello T, Helia ; Sepúlveda A, Marcela ; Mella M, Sergio ; Zemelman M, Claudia ; Zemelman Z, Raúl</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-4dbe46d95c8291156e52572dabdf2d059bf360cb5a0483012578c1177721af9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2007</creationdate><topic>Acinetobacter baumannii - drug effects</topic><topic>Acinetobacter baumannii - enzymology</topic><topic>Acinetobacter baumannii - isolation & purification</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacterial Proteins - biosynthesis</topic><topic>beta-Lactam Resistance</topic><topic>beta-Lactamases - biosynthesis</topic><topic>Chile</topic><topic>Drug Resistance, Bacterial</topic><topic>Humans</topic><topic>Isoelectric Focusing</topic><topic>Microbial Sensitivity Tests</topic><toplevel>online_resources</toplevel><creatorcontrib>Pino I, Carolina</creatorcontrib><creatorcontrib>Domínguez Y, Mariana</creatorcontrib><creatorcontrib>González R, Gerardo</creatorcontrib><creatorcontrib>Bello T, Helia</creatorcontrib><creatorcontrib>Sepúlveda A, Marcela</creatorcontrib><creatorcontrib>Mella M, Sergio</creatorcontrib><creatorcontrib>Zemelman M, Claudia</creatorcontrib><creatorcontrib>Zemelman Z, Raúl</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista chilena de infectología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pino I, Carolina</au><au>Domínguez Y, Mariana</au><au>González R, Gerardo</au><au>Bello T, Helia</au><au>Sepúlveda A, Marcela</au><au>Mella M, Sergio</au><au>Zemelman M, Claudia</au><au>Zemelman Z, Raúl</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extended spectrum beta lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII Region</atitle><jtitle>Revista chilena de infectología</jtitle><addtitle>Rev Chilena Infectol</addtitle><date>2007-04</date><risdate>2007</risdate><volume>24</volume><issue>2</issue><spage>137</spage><pages>137-</pages><issn>0716-1018</issn><abstract>The resistance of Acinetobacter baumannii to ss-lactam antibiotics is mainly due to the synthesis of ss-lactamases. From a clinical point of view, this bacteria and others, grouped under the acronym SPACE (S: Serratia, P: Pseudomonas, A: Acinetobacter, C: Citrobacter, E: Enterobacter) are essentially Amp-C ss-lactamases producers. There is no local information about ESBL presence in Acinetobacter. We studied ESBL production using the Ho and col. technique modified by adding cloxacillin as chromosomal ss-lactamases inhibitor. From 69 isolates, with resistance to at least one third generation cephalosporin, only 7 showed positive synergy test. Four of these amplified for TEM family gene, and one of these amplified also for the OXA family. Our study found a low ESBL production percentage, which agrees with the premise of Amp-C as the main mechanism of resistance to ss-lactam antibiotics in A. baumannii. However, the ESBL description in these bacteria emphasizes the capacity of expressing multiple resistance mechanisms.</abstract><cop>Chile</cop><pmid>17453072</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0716-1018 |
ispartof | Revista chilena de infectología, 2007-04, Vol.24 (2), p.137 |
issn | 0716-1018 |
language | spa |
recordid | cdi_pubmed_primary_17453072 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Acinetobacter baumannii - drug effects Acinetobacter baumannii - enzymology Acinetobacter baumannii - isolation & purification Anti-Bacterial Agents - pharmacology Bacterial Proteins - biosynthesis beta-Lactam Resistance beta-Lactamases - biosynthesis Chile Drug Resistance, Bacterial Humans Isoelectric Focusing Microbial Sensitivity Tests |
title | Extended spectrum beta lactamases (ESBL) production in Acinetobacter baumannii strains isolated from Chilean hospitals belonging to VIII Region |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T15%3A01%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extended%20spectrum%20beta%20lactamases%20(ESBL)%20production%20in%20Acinetobacter%20baumannii%20strains%20isolated%20from%20Chilean%20hospitals%20belonging%20to%20VIII%20Region&rft.jtitle=Revista%20chilena%20de%20infectolog%C3%ADa&rft.au=Pino%20I,%20Carolina&rft.date=2007-04&rft.volume=24&rft.issue=2&rft.spage=137&rft.pages=137-&rft.issn=0716-1018&rft_id=info:doi/&rft_dat=%3Cpubmed%3E17453072%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17453072&rfr_iscdi=true |